Shanghai Junshi Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Junshi Biosciences has a total shareholder equity of CN¥7.0B and total debt of CN¥3.0B, which brings its debt-to-equity ratio to 42.9%. Its total assets and total liabilities are CN¥12.0B and CN¥5.0B respectively.
Key information
42.9%
Debt to equity ratio
CN¥3.01b
Debt
Interest coverage ratio | n/a |
Cash | CN¥4.56b |
Equity | CN¥7.02b |
Total liabilities | CN¥5.01b |
Total assets | CN¥12.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688180's short term assets (CN¥6.2B) exceed its short term liabilities (CN¥3.0B).
Long Term Liabilities: 688180's short term assets (CN¥6.2B) exceed its long term liabilities (CN¥2.0B).
Debt to Equity History and Analysis
Debt Level: 688180 has more cash than its total debt.
Reducing Debt: 688180's debt to equity ratio has increased from 20.6% to 42.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688180 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 688180 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.